Comparing the Effects of Lactated Ringers and Normal Saline in Acute Pancreatitis
Mitigating the Inflammatory Response in Acute Pancreatitis With Appropriate Fluid Management; A Randomized Clinical Control Trial Comparing the Effects of Lactated Ringers and Normal Saline
1 other identifier
interventional
79
1 country
3
Brief Summary
Acute pancreatitis is increasingly common diagnosis in children. Most of the guidelines related to the details of management of acute pancreatitis are extrapolated from the adult literature. There is only limited data regarding management of acute pancreatitis in children. The mainstay of management is bowel and pancreatic rest with significant fluid support to minimize the effect of the cytokines on the pancreas and other organs. The standard fluid choices are Lactated Ringer's solution (LR) and normal saline (NS). Currently, both LR and NS are used at the discretion of the treating physician as the standard of care for acute pancreatitis. The investigators hope to examine the question of ideal fluid choice for fluid resuscitation in children with acute pancreatitis by assessing recovery time in the context of measured inflammatory markers and SIRS status at 24 and 48 hours after admission. The ideal fluid choice in the initial resuscitation of acute pancreatitis has not been effectively evaluated before in the pediatric population. Even if there is no statistically significant difference between the two fluid options, this trial will still provide clinically significant information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2014
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 22, 2016
CompletedFirst Posted
Study publicly available on registry
August 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2020
CompletedAugust 17, 2021
August 1, 2021
5.9 years
August 22, 2016
August 11, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
C-Reactive Protein (CRP)
Primary marker of inflammation, change measured at baseline and then every 24 hours for 48 hours
At admission, 24 and 48 hours
Secondary Outcomes (6)
Blood Urea Nitrogen (BUN)
At admission, 24 and 48 hours
Serum Amylase
At admission, 24 and 48 hours
Serum Lipase
At admission, 24 and 48 hours
Average length of stay
Total length of stay in the hospital, measured in hours, usually around 4 days (96 hours).
Time to initiation of enteral feeds
Total length of time to initiate feeds in the hospital, measured in hours, usually around 2 days (48 hours).
- +1 more secondary outcomes
Study Arms (2)
Lactated Ringers (LR)
EXPERIMENTALThe subject will be placed on 1.5x maintenance IVF with the fluids to which they are randomized. Fluid Management will be the intervention.
Normal Saline (NS)
EXPERIMENTALThe subject will be placed on 1.5x maintenance IVF with the fluids to which they are randomized. Fluid Management will be the intervention.
Interventions
The patient will remain NPO for at least the first 24 hours. The following studies will be obtained at the time of admission if not previously obtained in the ED: CMP, GGT, Amylase, Lipase, Triglycerides, CBC, and CRP, along with an abdominal ultrasound. CBC, CRP, BMP, amylase and lipase levels will be obtained at 24 and 48 hours (+/- 2 hours). SIRS status will be evaluated with vital sign checks every 4 hours and the leukocyte counts every 24 hours.
Eligibility Criteria
You may qualify if:
- Patients aged 0-18 years diagnosed with acute pancreatitis in the emergency department or inpatient ward at Children's Hospital of The King's Daughters or one of the affiliated institutions participating in the study.
You may not qualify if:
- Patients greater than 18 years of age
- Patients who are not diagnosed with acute pancreatitis
- Patients who have any previous history of acute pancreatitis, past medical history of underlying illness including congenital heart disease, chronic lung disease, or renal failure
- Patients who have any of the following: hyperkalemia, systemic acidosis, acute dehydration, extensive tissue breakdown, adrenal insufficiency, concomitant use of potassium-sparing diuretics, use of extended-release preparations in patients with esophageal compression caused by an enlarged left atrium, hypersensitivity to sodium chloride, hypernatremia, or fluid retention
- Patients who are pregnant females
- Patients who have additional comorbidities at time of admission that would prevent adequate treatment with the methods described above will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Children's National Health System
Washington D.C., District of Columbia, 20010, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Children's Hospital of The King's Daughters
Norfolk, Virginia, 23507, United States
Related Publications (6)
Srinath AI, Lowe ME. Pediatric pancreatitis. Pediatr Rev. 2013 Feb;34(2):79-90. doi: 10.1542/pir.34-2-79. No abstract available.
PMID: 23378615BACKGROUNDSarr MG. Early fluid "resuscitation/therapy" in acute pancreatitis: which fluid? What rate? What parameters to gauge effectiveness? Ann Surg. 2013 Feb;257(2):189-90. doi: 10.1097/SLA.0b013e318280e19e. No abstract available.
PMID: 23291660BACKGROUNDMeyer A, Coffey MJ, Oliver MR, Ooi CY. Contrasts and comparisons between childhood and adult onset acute pancreatitis. Pancreatology. 2013 Jul-Aug;13(4):429-35. doi: 10.1016/j.pan.2013.06.005. Epub 2013 Jun 27.
PMID: 23890143BACKGROUNDWu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S, Smith B, Banks PA, Conwell DL. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011 Aug;9(8):710-717.e1. doi: 10.1016/j.cgh.2011.04.026. Epub 2011 May 12.
PMID: 21645639BACKGROUNDGoldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005 Jan;6(1):2-8. doi: 10.1097/01.PCC.0000149131.72248.E6.
PMID: 15636651BACKGROUNDFarrell PR, DesPain AW, Farmer P, Farrell LM, Greenfield B, Rogers ME, Hornung L, Kim E, Pearman R, Neway B, Thompson T, Heubi JE, Sehgal S, Amoury R, Abu-El-Haija M. Faster discharge with lactated ringers than normal saline in first 72 h of acute pancreatitis: A multicenter randomized trial. J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):360-368. doi: 10.1002/jpn3.12082. Epub 2023 Dec 11.
PMID: 38374568DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter R Farrell, MD
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Sona Sehgal, MD
Children's National Research Institute
- PRINCIPAL INVESTIGATOR
Rana Ammoury, MD
Children's Hospital of The King's Daughters
- PRINCIPAL INVESTIGATOR
Maisam Abu-El-Haija, MD
Children's Hospital Medical Center, Cincinnati
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Fellow, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition
Study Record Dates
First Submitted
August 22, 2016
First Posted
August 8, 2017
Study Start
December 1, 2014
Primary Completion
October 23, 2020
Study Completion
October 23, 2020
Last Updated
August 17, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data will be shared for up to 3 years after the conclusion of recruitment.
We plan to share the de-identified data obtained at CCHMC with our partners at CHKD and Children's National Medical Center, and we intend to have them share their data with us as well.